Fibroblast biology -: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis

被引:392
作者
Pap, T
Müller-Ladner, U
Gay, RE
Gay, S
机构
[1] Univ Zurich Hosp, Dept Rheumatol, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Rheumatol, WHO, Collaborating Ctr Mol Biol & Novel Therapeut Stra, CH-8091 Zurich, Switzerland
[3] Univ Regensburg, D-8400 Regensburg, Germany
关键词
fibroblasts; rheumatoid arthritis;
D O I
10.1186/ar113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is growing evidence that activated synovial fibroblasts, as part of a complex cellular network, play an important role in the pathogenesis of rheumatoid arthritis. In recent years, significant progress has been made in elucidating the specific features of these fibroblasts. It has been understood that although macrophage and lymphocyte secreted factors contribute to their activation, rheumatoid arthritis synovial fibroblasts (RA-SFs) do not merely respond to stimulation by pro-inflammatory cytokines, but show a complex pattern of molecular changes also maintained in the absence of external stimulation. This pattern of activation is characterized by alterations in the expression of regulatory genes and signaling cascades, as well as changes in pathways leading to apoptosis. These together result in the upregulation of adhesion molecules that mediate the attachment of RA-SFs to the extracellular matrix and in the overexpression of matrix degrading enzymes that mediate the progressive destruction of the joints. In addition, activated RA-SFs exert specific effects on other cell types such as macrophages and lymphocytes. While the initiating step in the activation of RA-SFs remains elusive, several key pathways of RA-SF activation have been identified. However, there is so far no single, specific marker for this phenotype of RA-SF. It appears that activated RA-SFs are characterized by a set of specific properties which together lead to their aggressive behavior.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 85 条
[1]  
AICHER WK, 1994, J IMMUNOL, V152, P5940
[2]  
Alsalameh S, 1999, SCAND J IMMUNOL, V49, P278
[3]   Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium [J].
Asahara, H ;
Fujisawa, K ;
Kobata, T ;
Hasunuma, T ;
Maeda, T ;
Asanuma, M ;
Ogawa, N ;
Inoue, H ;
Sumida, T ;
Nishioka, K .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :912-918
[4]   The AP-1 site and MMP gene regulation: What is all the fuss about? [J].
Benbow, U ;
Brinckerhoff, CE .
MATRIX BIOLOGY, 1997, 15 (8-9) :519-526
[5]  
Bendele A, 1999, J RHEUMATOL, V26, P1225
[6]  
Brennan FM, 1997, BRIT J RHEUMATOL, V36, P643
[7]   THE MEASUREMENT OF COLLAGENASE, TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP), AND COLLAGENASE TIMP COMPLEX IN SYNOVIAL-FLUIDS FROM PATIENTS WITH OSTEOARTHRITIS AND RHEUMATOID-ARTHRITIS [J].
CLARK, IM ;
POWELL, LK ;
RAMSEY, S ;
HAZLEMAN, BL ;
CAWSTON, TE .
ARTHRITIS AND RHEUMATISM, 1993, 36 (03) :372-379
[8]   Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis [J].
Cunnane, G ;
FitzGerald, O ;
Hummel, KM ;
Gay, RE ;
Gay, S ;
Bresnihan, B .
RHEUMATOLOGY, 1999, 38 (01) :34-42
[9]   Impaired Fas response and autoimmunity in Pten+/- mice [J].
Di Cristofano, A ;
Kotsi, P ;
Peng, YF ;
Cordon-Cardo, C ;
Elkon, KB ;
Pandolfi, PP .
SCIENCE, 1999, 285 (5436) :2122-2125
[10]  
Dike LE, 1996, J CELL SCI, V109, P2855